We issue permits for the secondary use of social and health data, combine data that is subject to a permit securely and pre-process the data ensuring the privacy of citizens.
On this page, you will find information on how to submit a permit application: what to consider before submitting it, how to submit the application, and what happens after submission.
Book a time for personal consultation
You can book a time for personal consultation with an expert from Findata. Appointments are available three days a week and last for 20 minutes. The meetings are held remotely via Teams.
We offer help in the following topics:
- General consultation on Findata’s services
- Data permit applications, amendments, and data requests
- Extraction description form and other forms
- Ordering Findata’s secure processing environment Kapseli, pausing, and data storage service
You can see the available times below.
Make sure you have written your email address correctly. After booking, we will send a confirmation to your email and a downloadable calendar reminder. We will send the link to the Teams meeting later.
If you have not received a confirmation or Teams link, email us at info@findata.fi.
The personal consultation service is provided as a part of the FinHITS project funded by the European Union.
What to remember before sending an application
Select the correct application type
There are different types of applications for different information needs
- Data permit application, when you need data on individuals
- Data request, when you need statistical data
- Amendment application, when you are applying for an amendment to a valid data permit
Describe and limit data
Define the data to be applied for at the variable level and remember the principle of minimisation for other information. Utilise the Data Resources Catalogue (aineistokatalogi.fi) and controller’s advisory services
- Where from and how do I extract the target group? Is the definition specific enough?
- Are control subjects/relatives extracted? How will they be defined?
- From which registers will the data be extracted?
- What variables will be included in the extraction?
Other data to be combined
- Have you made sure that the other data is described on the application?
- Are the permits for other data valid or is the permit process pending?
Determine the competent authority
We grant permits for the secondary use of social and health data when the application applies to
- Data from several public social and health sector controllers covered by the Finnish Secondary Use Act
- Data from a single public controller that has transferred the right to issue permits to Findata (see the list)
- Data from one or more private social welfare and health care service organisers
- Data saved in the Kanta Services
- Data in Findata’s ready-made dataset
Before applying
For what purposes can a permit be granted?
A permit can be granted for purposes defined in the Secondary Use Act.
Individual-level data
- education
- planning and reporting duty of an authority
- scientific research
- statistics
Data controllers may also use their own datasets for data-driven management without a separate data permit.
Statistical data
- development and innovation activities
- education
- knowledge management (comparative data)
- planning and reporting duty of an authority
- scientific research
- statistics
- steering and supervision of social and health care by authorities
As a rule, the Secondary Use Act applies to register-based studies. A register-based study uses register data that has typically been collected for other purposes, or data from national registers.
The Act does not apply to clinical trials reported to the Finnish Medicines Agency (Fimea) or to medical research conducted under the Medical Research Act.
Read more about the use purposes
Development and innovation activities
Development and innovation activities refer to application and use of technical and business data and other existing data together with the personal data referred to in the Secondary Data Act for the purpose of developing new or significantly improved products, processes or services.
In addition, the purpose of the activities must be to
- promote national health or social security
- develop social welfare and health care services for service systems
- protect individuals’ health or well-being or
- secure for them their related rights and freedoms.
Education
When data is to be used for education, the applied for data will be used to prepare teaching materials for personnel and persons studying to become social welfare and health care personnel who process customer data and social welfare and health care professionals. Please note: Data containing identifiers can only be used in teaching situations if teaching cannot be carried out anonymously due to the exceptional nature of the case, the nature of teaching or a similar reason. The person providing teaching must inform their students of the confidentiality provisions in legislation and the sanctions resulting from their violation.
Knowledge management
Knowledge management refers to the processing of data carried out by a service provider in their customer, service and production processes for the purpose of supporting
- operations, production and financial control
- management and
- decision-making.
Planning and reporting duty of an authority
As a rule, only an authority may carry out the planning and reporting duties of an authority. If an authority does not act as the applicant in a data permit application, the authority must be the controller of the data. As a rule, when work is commissioned, the commissioning party will be the processor of personal data.
Scientific research
When data is to be used for scientific research, attach an up-to-date research plan and a research permit from the responsible/target organisation to your application. Also attach an opinion from the Ethics Committee, if the legislation applying to the research and/or the research setup so requires.
Criteria for scientific research (in general):
- an appropriate research plan
- responsible person or group
- results to be published as a scientific publication
- research produces new information.
Statistics
When data is to be used to form statistics, state in the application which party will compile the statistics and for what purpose.
Steering and supervision of social and health care by authorities
A social and health care regulatory or supervisory authority may request aggregated statistical data from Findata by means of a data request if it needs data under the Secondary Use Act in order to carry out its steering or supervisory task.
Upon reasoned request, the data may also be provided in identifiable form if the supervisory authority is entitled to receive them under other legislation, irrespective of confidentiality obligations.
When do I submit an application to Findata?
Submit your data permit, data request or amendment permit application to Findata if you want to apply for:
- Data from several public social and health sector controllers
- Data from a single public controller that has transferred the right to issue permits to Findata
- Data from one or more private social welfare and health care service organisers
- Customer data saved in the Kanta Services
- Findata’s ready-made dataset
Unsure where to send your application? Use Application Assistant!
Public sector social and health controllers are divided into two groups under the Secondary Use Act, each with different competences. The following section explains these groups and their roles.
Public sector controllers: Group 1
- Finnish Institute of Occupational Health (TTL)
- Ministry of Social Affairs and Health (STM)
- Public service providers of social welfare and health care
- Social Insurance Institution (Kela)
You may apply for a data permit from Findata when your application concerns data from at least two data controllers in this group.
Data obtained through Findata may also be linked with other data covered by the Secondary Use Act.
Public sector controllers: Group 2
- Digital and Population Data Services Agency (DVV):
- Basic personal data, family relations, place of residence, and building details.
- If other data is required, DVV is responsible for granting the permit.
- Finnish Centre for Pensions
- Employment and earnings data of individuals
- Granted benefits and their grounds, including disability pension diagnoses
- If other information is needed, the Finnish Centre for Pensions is responsible for granting the permit.
- Statistics Finland:
- Information for determining cause of death.
- If other data is required, Statistics Finland is responsible for granting the permit.
You may apply for a data permit from Findata for data held by the DVV or Statistics Finland, if the data is combined with:
- data stored in the Kanta Services.
- data from one or more public data controllers in Group 1,
- data from one or more private social or health care service providers, or
Public sector controllers: Group 3, data controllers that have transferred permit authority to Findata
- Digital and Population Data Services Agency (DVV)*
- Finnish Centre for Pensions (ETK)*
- Finnish Medicines Agency Fimea
- Finnish Supervisory Authority
- Finnish Institute for Health and Welfare (THL)
- Except for internal permit administration and permit processing related to samples and data transferred to the THL Biobank
- Finnish Medicines Agency Fimea
- Finnish Supervisory Agency
- Wellbeing Services County of Eastern Uusimaa
* Findata grants the permit when data are combined with other data than data from the Digital and Population Data Services Agency, the Finnish Centre for Pensions and/or Statistics Finland.
Public data controllers may authorise Findata to grant permits and process data on their behalf under the Secondary Use Act.
In these cases, Findata processes all data request, data permit, and amendment applications concerning data held in the registers of the relevant data controller.
Where can data be analysed?
Data request | Aggregated statistical data
- Statistical data is sent to the applicant and can be analysed according to the data utilisation plan.
- The statistical data is primarily delivered to the customer through the secure Tunneli transfer service.
- Read more: Data transfers
Data permit | Individual-level data
- Individual-level data may only be analysed in a secure processing environment.
- Secure processing environments that meet the required standards are listed in the Astori register (lvv.fi).
- Amendment permits are officially considered data permits and are therefore generally subject to the same requirements as data permits.
- You may apply to Findata for permission to process individual-level data in a processing environment other than one compliant with the Secondary Use Act, provided that the security requirements are met.
- Read more: Instructions for applying for another secure processing environment
Regulation on secure processing environments
Findata has issued a regulation specifying the information security requirements for secure processing environments used for secondary use of social and health data.
These requirements apply to all purposes covered by the Act on the Secondary Use of Health and Social Data, including:
- Scientific research
- Statistics
- Teaching (only for preparing teaching materials, not actual teaching)
- Planning and investigation tasks of public authorities
Since 1 May 2022, compliance with these requirements has been mandatory for any data processed outside Findata’s Kapseli environment. In addition, the processing environment must be assessed by a data security assessment body that must issue a certificate on the assessment.
The regulation allows for different technical solutions. Secure environments may range from:
- A physically and technically secure space with an isolated analysis device
- Cloud-based solutions, provided they meet the required security standards
Foreign researchers’ processing environments must also comply with these requirements. Compliance can be demonstrated through internationally recognised security certifications, verified by an approved Finnish assessment body.
Read more on the Regulation on processing environments page.
Data permit | Anonymised dataset
- Anonymised datasets may be disclosed for analysis outside a secure processing environment.
- This requires that there is a justified special reason for processing the data outside a secure processing environment, that the related risks are low, and that the data can be anonymised reliably.
- If the data cannot be anonymised reliably enough, it will instead be disclosed to a secure processing environment.
Disclosure of anonymised data outside a secure processing environment
Under section 51 d of the Secondary Use Act, Findata may, for a specific reason, grant a data permit allowing anonymised data to be disclosed outside a secure processing environment.
A permit for anonymised data may be granted if all three of the following conditions are met:
- the data cannot, for justified reasons, be processed in a secure processing environment
- the risks related to the data are considered low
- the data can be anonymised reliably
In the application, the applicant must explain why the data cannot be processed in a secure processing environment compliant with the Secondary Use Act. The application must include sufficient information for Findata to assess whether the conditions are met.
If the application does not meet the required conditions, it will be processed as a standard data permit application. In that case, the data will be disclosed to a secure processing environment in accordance with section 20 of the Act.
How to apply
- Apply for a data permit for anonymised data in Findata’s e-service using the standard data permit application form.
- In the application, indicate that you are applying for disclosure of anonymised data under section 51 d of the Secondary Use Act.
- Complete and attach the supplementary information form:
- In the form, describe:
- why the data cannot be processed in a secure processing environment
- why the risks related to the data are considered low
- how the data can be anonymised reliably
- You may also attach a separate anonymisation plan to the application.
- Findata will assess the application and may request additional information if needed.
- Once the permit has been granted, Findata will deliver the data to the permit holder either by email or through the secure Tunneli transfer service.
Please note that anonymised data does not provide the same level of usability as personal data. If the data cannot be anonymised reliably, it will instead be disclosed to a secure processing environment. For this reason, the application must also specify the secure processing environment to which the data will be disclosed in such cases.
Clinical research and the use of register data
When is the Secondary Use Act not applied?
- The Secondary Use Act is not applied to clinical research when the research is based on consent and conducted under the following acts:
- Act on Clinical Drug Trials
- Medical Research Act
- Act on Medical Devices
- Clinical drug trials must be notified to the Finnish Medicines Agency Fimea. You can check the definitions of interventional clinical drug trials and non-interventional studies in Fimea Regulation 8/2019. Fimea provides guidance on whether a study is considered a clinical drug trial.
When is the Secondary Use Act applied?
- The Secondary Use Act is applied when register data are combined with a clinical study for individuals who have not given consent to the clinical study.
- In practice, this most often concerns the use of register data on relatives and/or control subjects
Where can clinical research data be analysed?
- Data that fall outside the scope of the Secondary Use Act can also be processed in secure processing environments compliant with the Secondary Use Act.
- Data may also be transferred to another processing environment if the following legal requirements for data disclosure and further processing are met:
- Section 34 of the Act on Clinical Drug Trials
- Section 21c of the Medical Research Act
- Section 20a of the Act on Medical Devices
- Please note that only data with a legal basis under one of the above provisions can be transferred. If part of the data in the processing environment falls under the Secondary Use Act, the requirements for processing environments laid down in the Act apply to that data.
Applying
Logging in to the e-service
Submit your application through Findata’s e-service using Suomi.fi authentication or Haka login. Always use the same authentication method when logging in, so that you can view your submitted applications and received decisions.
More information: Login
Instructions by permit type
See the permit-specific pages for detailed instructions on how to submit an application.
- Data permit application | Individual-level data or anonymised dataset
- Data request | Statistical-level data
- Amendment application | Changes to an existing valid data permit
How to speed up the processing of your application
- Check whether Findata is the competent authority to issue a permit for the data you need.
- Use Application assistant
- If you are unsure where your application should be submitted, please contact our advisory service before submitting your application: info@findata.fi.
- If you need more information about the data or variables, contact the relevant data controllers directly.
- Data controllers provide advisory services for their data and can guide you on data extraction methods.
- You may also agree on the details of data extraction directly with the data controller. If you do so, please include the name of the person you have agreed this with in your application.
- Read more: Links to data controllers’ websites and data descriptions
- Specify your data needs and dataset extraction requirements as precisely as possible for each data controller.
- Use the extraction description form to define your data extractions: Extraction description form (Word file, 51.2 kb)
- Use tabulation plan form to describe the statistics generation if you are applying for a statistical: Tabulation plan (Excel file, 19,2 kB)
- Use the Data Resources Catalogue (aineistokatalogi.fi)
- Ensure appropriate scope of data extraction
- The disclosure of personal data is governed by the GDPR principle of data minimisation. This means that only the data that is strictly necessary may be disclosed.
- Data extraction may still be broad, as long as the need for the data is justified.
- Complete your application carefully
- Pay particular attention to basic information such as the applicant, the data controller of the dataset to be disclosed, billing details, and any other datasets to be linked.
Transfer of personal data outside the EU/EEA
The processing of personal data from abroad is, by default, considered a transfer of personal data, even if the data is in a remote access environment.
The affiliation of the data processor with the data controller may affect this assessment. If the data processor is employed by a data controller located within the EU/EEA, processing from abroad is not considered a data transfer, and the processor may access the data from outside the EU/EEA.
Example: Transfer of personal data outside the EU/EEA
- Findata has granted a data permit concerning datasets from HUS, Pirha, and Varha.
- According to the data permit, the data processors are employees of HUS, Pirha, and Varha.
- The data controller of the dataset is HUS, as stated in the data permit.
- The data is processed within Findata’s secure Kapseli environment.
- If the data processors travel to the United States for a conference: An employee of HUS can process the data remotely via Kapseli from the U.S., as they are employed by the data controller.
- Employees of Pirha and Varha, however, are not employed by the data controller (HUS), meaning they cannot process the data in Kapseli from the U.S. without a legal basis under Chapter V of the GDPR.
Under the EU’s General Data Protection Regulation (GDPR), data can be transferred within the European Economic Area (EEA) under the same conditions as within Finland. The EEA includes EU Member States, Norway, Liechtenstein, and Iceland.
For data transfers or processing outside the EEA, in so-called third countries, there must be a legal basis as outlined in Chapter V of the GDPR. The acceptable legal bases for such transfers are listed below. It is sufficient to meet just one of these bases.
Commission decision in the adequacy of data protection under Article 45
- An up-to-date list on countries whose data protection has been assessed as adequate with a decision by the European Commission (commission.europa.eu)
- If the requirements for the transfer are met on this basis, no other measures are required, and we will take this criterion into account as a factor justifying the transfer in the data permit decision. This ‘safe country’ principal is the primary basis for data transfer.
- For more information, see the website of the Data Protection Ombudsman (tietosuoja.fi).
Standard contractual clauses on data protection pursuant to Article 46(2)
- Standard contractual clauses (SCC) are standard contractual clauses approved by the European Commission that can be used in contracts between two controllers or between a controller and a processor.
- These standard clauses can be viewed on the website of the Data Protection Ombudsman (tietosuoja.fi).
- If this is given as the basis for data transfer, we will take this criterion into account in the data permit decision. We will make the data available outside the EU/EEA subject to this condition and only after the applicant or permit holder has submitted to Findata the signed standard contractual clauses. The use of standard clauses will also require additional examination of the adequacy of data protection. Please note that standard contractual clauses may not be modified or added to, but must be approved as they are.
Binding corporate rules pursuant to Article 47
- Binding corporate rules (BCR) refer to shared, binding rules for the transfer of personal data to third countries within a corporate group or group of companies engaged in joint economic operations.
- For more information, see the website of the Data Protection Ombudsman (tietosuoja.fi).
- If this is given as the basis for data transfer, we will take this criterion into account in the data permit decision. We will make the data available outside the EU/EEA area subject to this condition and only after the applicant or permit holder has notified the Findata of the code of conduct in question, which must have been appropriately approved by a data protection ombudsman of an EU Member State.
Exceptions and safeguards under Article 49
Exceptions and safeguards under Article 49, such as the explicit consent of the subject to the proposed transfer after being informed of the risks associated with the transfer. This basis for transfer can only be used in exceptional cases.
- For more information, see the website of the Data Protection Ombudsman (tietosuoja.fi).
- When appealing to this legal basis when utilising data subject to a permit, the controller or the processor must describe in their report on processing operations the assessment related to the transfer and the appropriate safeguards established. For more information, see the website of the Data Protection Ombudsman (tietosuoja.fi).
- If this is given as the basis for data transfer, we will take this criterion into account in the data permit decision.
For information on transferring data to the United Kingdom following Brexit, visit the Data Protection Ombudsman’s website (tietosuoja.fi).
Permit fees and other costs
Fees are charged for decisions on data permit applications, data requests, and amendment applications, including the related data processing.
The total cost consists of three parts:
- Findata’s decision fee (data permit, amendment permit or data request)
- Costs charged by data controllers for data extraction and delivery
- Findata’s hourly fee for data linkage, pre-processing, pseudonymisation
A separate processing fee is charged for negative decisions and for applications that expire.
Findata’s decision fees and data processing charges are based on the fee regulation issued by the Ministry of Social Affairs and Health. These are public administrative fees and are not subject to VAT.
Before data processing begins, we will provide an estimate of Findata’s processing costs, as well as an estimate from the data controllers for data extraction costs. The final price is confirmed when the data is ready to be disclosed to the permit holder. Findata and the data controllers issue invoices separately to the permit holder.
For more details, visit the Pricing page.
After applying
How does Findata process applications?
- Contact data controllers directly for additional information on data or variables.
- Data controllers provide additional information about their own datasets.
- You may also request a cost estimate and an assessment of the feasibility of the data extraction.
- Use the extraction description form to define your data extractions: Extraction description form (Word file, 51.2 kb)
- Use tabulation plan form to describe the statistics generation if you are applying for a statistical: Tabulation plan (Excel file, 19,2 kB)
- You may also agree on the details of data extraction directly with the data controller. If you do so, please include the name of the person you have agreed this with in your application.
- Submit your application via Findata’s e-service
- Log in to the e-service: asiointi.findata.fi
- Findata reviews the application and invites you to an online meeting
- We review applications within approximately one week of submission.
- We invite the applicant to a Teams meeting to go through the application and ask clarifying questions if needed.
- We may ask you to supplement the application.
- Findata requests cost estimates and additional information from data controllers
- Once the extraction descriptions are complete, we will send requests for additional information and cost estimates to the relevant data controllers.
- Data controllers have 15 working days to respond.
- If further clarification is needed, data controllers may send questions via Findata to the applicant.
- Findata compiles the cost estimates from both data controllers and Findata’s own data processing costs and sends them to the applicant.
- After receiving all cost estimates from data controllers, we assess the working time and costs required for data processing.
- We then deliver the final extraction description and cost estimate to the applicant.
- The extraction description must be approved before a permit can be granted.
- Extraction terms cannot be changed after approval. Any later changes to the extracted data require a separate application.
- Findata issues a decision
- Data permits are for a fixed period.
- If data needs to be retained, for example for research verification purposes, or if permit renewal or regular updates of data extractions are expected, please indicate this in the application.
How does Findata compile the data?
- Findata sends data extraction requests to controllers who extract the data
- Each controller has 30 working days to submit the requested data to Findata.
- The extraction may involve multiple steps, such as:
- Extraction of the target group
- Extraction of controls
- Extraction of additional data
- Each step can take up to 30 working days, potentially totaling up to 90 working days.
- Findata pre-processes the extracted data
- We will review, combine, and pseudonymise the data or generate statistics according to the data request.
- Findata delivers the data to the permit holder
- The processed data will be provided to a secure processing environment, typically in CSV format.
- The target time for delivering the data is 60 working days.
- This timeframe may be extended if the target group is not provided immediately, if extraction is conducted in multiple stages, if there are delays from controllers, or if the data is particularly complex.
- Permit holder reviews the data
- You have three months to review the data and notify Findata of any discrepancies or comments.
- Thoroughly check the data, as errors can lead to additional work.
- For example, errors that occur during extraction can accumulate, such as if the target group is formed incorrectly, requiring additional extractions from other controllers.
- If you find omissions or errors, email Findata at data@findata.fi with detailed descriptions of how your data differs from the extraction description.
- Findata deletes the data from its own processing systems once the retention period has expired.
- We remove the datasets from our systems four months after delivery.
- We retain the code keys for pseudonymised data to allow reproduction if needed.
- Data permits are for a fixed period.
- If you need to save data for purposes like research verification, plan to renew the permit, or require regular updates, include these needs in your application.
Errors or omissions in data
- Upon receiving the data, review it as soon as possible, but no later than within three months.
- If you notice any omissions or errors, contact Findata at data@findata.fi.
- In your message, explain precisely how your data differs from the data described in the extraction description.
Data extractions under a data permit or request are always based on the extraction description. If the description you provided is incomplete, you can complete the extraction by submitting an amendment application or a new application for a data permit to Findata.
The maximum price estimates given are based on the extraction description the applicant has provided. If the extraction needs to be completed, a new maximum price estimate will be submitted with the new permit.
Clinically significant findings
Under Section 55 of the Secondary Use Act, a data permit holder may notify Findata of a clinically significant finding that could make it possible to prevent a health-related risk for a specific patient or to significantly improve the quality of care.
Findata forwards the information to designated experts at the Finnish Institute for Health and Welfare (THL), who assess the significance of the information and the expected benefits of any feasible actions based on it.
If the finding is considered significant and the individual could benefit from an existing treatment, THL forwards the information to the wellbeing services county responsible for the individual’s care.
An employee of the wellbeing services county will contact the individual concerned, unless the person has refused to be contacted on the basis of a clinically significant finding.
How to report a clinically significant finding to Findata
- Fill in the following forms:
- Annex 1: Enter the subject’s pseudonym / personal identity code and project details on the form. Personal data will be kept separate during the process to avoid unnecessary identification of the subject and to enhance data protection.
- Annex 2: Fill in the relevant information on the form regarding the finding and any characteristics of the subject.
- THL experts do not have access to the patient’s health data for the purpose of making the decision, so the decision will be based on the information provided.
- Send an email to data@findata.fi, stating that you wish to report a significant clinical finding.
- Do not send personal data by email!
- Use the following subject line: Clinically significant finding.
- You will receive a reply message with instructions on how to deliver the information to Findata.
- Personal data must be delivered securely via the Tunneli transfer service.
- If you do not have Tunneli credentials, order them according to the instructions: Data transfers to Findata.
- See the section Open the Tunneli connection.
- In the credentials order form, enter the case number of the data permit based on which the clinically significant finding was identified (e.g. THL_1234_14.02.00_2020). Enter “pykälä55” in the Identifier field.
- If you already have Tunneli credentials, we will share a Tunneli folder for you to deliver the information. Transfer the files according to the instructions: Data transfers to Findata.
- See the section “Encrypt your data resource and transfer it to Tunneli”.
- Once you have delivered the files, notify us by email at data@findata.fi
- Deliver the following documents to Findata via Tunneli:
- Annex 1
- Annex 2
- Research plan and summary of the research plan (including the research group’s contact details)
- Once Findata has acknowledged receipt of the data, delete all information related to the findings from your local machine.
The Finnish Institute for Health and Welfare (THL) will process the findings within approximately four weeks. During holiday periods, processing may take longer. The permit holder will not be automatically notified of the decision. If desired, the permit holder may request confirmation that the finding has been processed, but not information on the outcome of the decision.
Exporting results from the processing environment and producing anonymous results
Results exported from a secure processing environment must be produced in an anonymous format, so that no individual person can be identified or any personal characteristics disclosed.
The permit holder anonymises results that will be exported from the secure processing environment, and Findata verifies the anonymity of the results through a risk-based assessment. Findata must be notified every time results are exported from a secure processing environment, regardless of whether the results involve a disclosure risk.
Read more
Report published research results to Findata
Use the form below to report articles and publications that have made use of data authorised by Findata. One of the criteria for the issuing of a data permit for the purpose of scientific research is that the results are published as scientific publications. The form can also be used to report publications of data authorised for other uses.
Reference guide
If Findata has granted a data permit or issued a data request decision for your project, please cite Findata in publications as “Finnish Social and Health Data Permit Authority Findata”.
Other recommendations:
- Follow the writing guidelines of the relevant scientific publication series.
- Reference Findata in line with our statutory duties. Under data permits, these include pseudonymisation and ensuring the anonymity of results, and under data requests, data integration, aggregation, and anonymisation.
- Findata may be referenced in the text, tables, figures, permit lists, acknowledgements, and reference lists.
- Where possible, include the diary number(s) of the data permit or data request in the citation.
Examples of in-text citations
“Research data was obtained from the Finnish Social and Health Data Permit Authority Findata with data permit THL/XXXX/14.XX.00/20XX. Findata was responsible for the pseudonymization of the data and ensuring the anonymity of the final results.”
“The statistics were produced by Findata, the Finnish Social and Health Data Permit Authority, with data request THL/XXXX/14.XX.00/20XX. Findata was responsible for data integration and producing the anonymized statistics.”
Example of table citation
| Data | Source |
|---|---|
| Research data | Finnish Social and Health Data Permit Authority Findata, data permit THL/XXXX/14.XX.00/20XX |
Example of citation in a reference list
Findata. (Year). Data permit THL/XXXX/14.XX.00/20XX. Finnish Social and Health Data Permit Authority Findata.
Published reserach results based on registry data permitted by Findata
Published research results
The table below contains information on publications that have used registry data authorised by Findata. Permit holders report their publications to Findata themselves.
Submit your publications here: Report published research results
Table updated: 18 November 2025
| Year of publication | Project name | Title of publication | Authors | Publication channel | DOI / Link to publication |
|---|---|---|---|---|---|
| 2025 | Ulkosynnytinsyövän leikkauskäytännöt – vaikutus leikkauskomplikaatioihin ja onkologiseen ennusteeseen | Electrothermal bipolar vessel sealing devices are associated with lower rates of postoperative complications compared to ultrasonic devices in vulvar cancer surgery. | Mörsky MK, Kaartinen IS, Nyberg RH | PLOS ONE, 20(10): e0335266 | https://doi.org/10.1371/journal.pone.0335266 |
| 2025 | Ulkosynnytinsyövän leikkauskäytännöt – vaikutus leikkauskomplikaatioihin ja onkologiseen ennusteeseen | Oncological outcomes, surgical margins, and adjuvant treatment delays in vulvar cancer patients with or without reconstruction during primary surgery. | Mörsky MK, Nyberg RH, Vuento MH, Staff S, Kaartinen IS | International Journal of Gynecological Cancer, 35(7):101942 | https://doi.org/10.1016/j.ijgc.2025.10194 |
| 2025 | REAL-WORLD EVIDENCE STUDY OF THE IMPACT OF ASCT AND NEW DRUG TREATMENTS ON MULTIPLE MYELOMA (MM) SURVIVAL AND COMORBIDITIES COMPARED TO non-MM CONTROL POPULATION IN FINLAND BETWEEN 2000-2020 | A real-world study on the impact of infection load on mortality in multiple myeloma patients in Finland. | Anttalainen A, Havula E, Kysenius K, Toppila I, Miettinen T, Lassenius M, Silvennoinen R, Partanen A, Putkonen M | Annals of Hematology, 104(4):2373–2385 | https://doi.org/10.1007/s00277-024-06101-3 |
| 2025 | Long Acting Injectable Buprenorphine Use in Finland | Early experiences of buprenorphine long-acting injection in Finland: a retrospective cohort study. | Partanen M, Saarenpää T, Prami T, Iso-Mustajärvi I, Vehkala M, Landelius Torper O, Ryder B, Simojoki K | Poster, International Society of Addiction Medicine (ISAM) Annual Conference, Hamburg, Germany | |
| 2025 | Jakavi (ruxolitinib) treatment outcomes in acute graft versus host disease (GvHD) in real-world setting in Helsinki and Turku University Hospitals | Ruxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in a real-world setting in Finland. | Martelin E, Kuikka A, Rajala H, Ruohonen T, Mönkkönen H, Vikkula J, Uusi-Rauva K, Salmenniemi U, Itälä-Remes M | Annals of Hematology, 104, 3451–3458 (2025) | https://doi.org/10.1007/s00277-025-06439-2 |
| 2025 | Multiple Myeloma (MM) – Characteristics, treatment praxis, Healthcare Resource Utilization (HCRU) and utilization of machine learning tools to identify novel risk factors | Evolution of treatment practices and outcomes in multiple myeloma during 2013–2022: a Finnish real-world registry study. | Partanen A, Waltari M, Vikkula J, Mattila R, Närhi K, Eeva J, Putkonen M | Acta Oncologica, 64:598–606 | https://doi.org/10.2340/1651-226X.2025.42647 |
| 2025 | Burden of illness in asthma and COPD | Burden of asthma by severity and exacerbation frequency among adult patients naive to biologic asthma therapy: a Finnish cohort study. | Kankaanranta H, Viinanen A, Klåvus A, Lassenius MI, Olsen HH, Nieminen K, Lyly A, Kauppi P, Lehtimäki L | Journal of Allergy and Clinical Immunology: Global, 4(2):100453 | https://doi.org/10.1016/j.jacig.2025.100453 |
| 2025 | Keskivaikean ja vaikean atooppisen ekseeman hoito ja dupilumabin käyttö Suomessa | Characterizing patients and treatment patterns in moderate-to-severe atopic dermatitis in Finland: a population-based study using national health data. | Remitz A, Peltonen EJ, Korhonen L, Nortamo P, Iso-Mustajärvi I, Prami T, Oinonen L, Gittens B, Von Arx LB, Porsdal V | Acta Dermato-Venereologica, 105, adv41244 | https://pubmed.ncbi.nlm.nih.gov/40271985/ |
| 2025 | Association between dental fear and the dental attendance of the family | Changes in oral health-related quality of life according to public oral health procedures in parents of young children from the FinnBrain Birth Cohort Study. | Palo K, Tolvanen M, Suominen A, Karlsson H, Karlsson L, Lahti S | Community Dentistry and Oral Epidemiology (Wiley), 53: 382-388. | https://onlinelibrary.wiley.com/doi/10.1111/cdoe.13039 |
| 2025 | Disease management, outcomes, and health care resource use associated with real-life clinical practice of diabetes and diabetic kidney disease in Finland (FinDIABREN-RWE) | Diabeteksen munuaistaudin toteaminen on puutteellista Keusoten alueella. | Laine MK, Haapala M, Uusi-Rauva K, Aakko J, Pentikäinen M, Mikkola K, Halonen N, Pulkki K, Säävuori N, Groop P-H, Metsärinne K | Suomen Lääkärilehti, 80:e43390 | https://www.laakarilehti.fi/e43390 |
| 2025 | FINHRBC – epidemiology and clinical characteristics of hormone receptor positive breast cancer patients in Finland | Real-world observational study of incidence and outcomes in an HR+/HER2– early breast cancer population with high risk of recurrence in Finland. | Singh, R., Tuominen, S., Lassenius, M.I. et al. | Oncology and Therapy 13, 185–200 (2025) | https://doi.org/10.1007/s40487-024-00324-0 |
| 2025 | Patient characteristics and treatment landscape of metastatic castration resistant prostate cancer in Finland | Real-world treatment patterns and survival outcomes in men with metastatic castration-resistant prostate cancer in Finland: a national, population-based cohort study. | Rannikko A, Hölsä O, Ågesen T, Ekman M, Mattila R | Acta Oncologica, 64:173–178 | https://doi.org/10.2340/1651-226X.2025.42173 |
| 2025 | The SORREL study – Prevalence, Characteristics, and Burden of Nasal Polyps in Chronic Rhinosinusitis Patients in Finland | Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps. | Toppila-Salmi S, Lyly A, Simin J, Aakko J, Haugom Olsen H, Lehtimäki L | Clinical and Translational Allergy, 2025;e70032 | https://onlinelibrary.wiley.com/doi/10.1002/clt2.70032 |
| 2025 | SOTE-PALVELUT LÄPINÄKYVIKSI: Palvelu- ja tietointegraatio yhtenäisen tietomallin ja yhdistetyn tietopohjan avulla | Changes in depression medication following the initial assessment by specialised psychiatry services in the Helsinki-Uusimaa Region | Juntura J, Näätänen P, Joffe G, Ekelund J, Leskelä R-L, Ito T, Rive B, Godinov Y, Eriksson I, Torkki P | EPA 2025 (Conference abstract) | |
| 2025 | Attention deficit hyperactivity disorder (ADHD) care in Finland | Use of Antidepressants Decreased After Initiation of ADHD Treatment in Adults—A Finnish Nationwide Register Study Describing Use of ADHD and Non-ADHD Medication in People With and Without ADHD | Westman E, Prami T, Kallio A, Iso-Mustajärvi I, Jukka J, Raittinen P, Korhonen MJ, Puustjärvi A, Leppämäki S | Acta Psychiatrica Scandinavica 152, no. 3 (2025): 203–215 | https://doi.org/10.1111/acps.70007 |
| 2025 | Työkyvyn tila Suomessa | Työkyvyn ja työhön osallistumisen kokonaisvaltainen tarkastelu ja palvelu- ja etuusjärjestelmän reunaehdot : Tutkimustuloksia päätöksenteon tueksi | Henriksson M, Mesiäislehto M, Ahola E, Joensuu M, Kärkkäinen S, Laaksonen J, Saikku P, Siltala V, Turunen J | Sosiaali- ja terveysministeriön raportteja ja muistioita 2025:5 | http://urn.fi/URN:ISBN:978-952-00-8681-7 |
| 2025 | Työkyvyn tila Suomessa | Tutkimus: työkykyä on tuettava työelämän muutoksissa ennen kuin työkyvyttömyysriskejä ilmaantuu | Sosiaali- ja terveysministeriö | Sosiaali- ja terveysministeriö | https://stm.fi/-/tutkimus-tyokykya-on-tuettava-tyoelaman-muutoksissa-ennen-kuin-tyokyvyttomyysriskeja-ilmaantuu |
| 2024 | REAL-WORLD EVIDENCE STUDY OF THE IMPACT OF ASCT AND NEW DRUG TREATMENTS ON MULTIPLE MYELOMA (MM) SURVIVAL AND COMORBIDITIES COMPARED TO non-MM CONTROL POPULATION IN FINLAND BETWEEN 2000-2020 | Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021. | Kysenius K, Anttalainen A, Toppila I, Miettinen T, Lassenius M, Lievonen J, Partanen A, Silvennoinen R, Putkonen M | Annals of Hematology, 103, 2931–2943 (2024) | https://doi.org/10.1007/s00277-024-05865-y |
| 2024 | Multiple Myeloma (MM) – Characteristics, treatment praxis, Healthcare Resource Utilization (HCRU) and utilization of machine learning tools to identify novel risk factors | A real-world study of multiple myeloma patients with at least 3 prior treatment lines and triple class exposed disease in Finland: outcomes and need for healthcare resource use. | Putkonen M, Kivioja A, Vikkula J, Waltari M, Mattila R, Närhi K, Eeva J, Partanen A | Value in Health, 27(12):S2 | https://www.ispor.org/heor-resources/presentations-database/presentation/euro2024-4018/143359 |
| 2024 | Raskauden aikaisen metformiini-altistuksen pitkäaikaiset vaikutukset lapseen Suomessa – CLUE-tutkimus | Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study. | Brand KMG, Saarelainen L, Sonajalg J, Boutmy E, Foch C, Vääräsmäki M, et al. | BMJ Open Diabetes Research & Care, 10(1):e002363 | https://drc.bmj.com/content/10/1/e002363 |
| 2024 | Raskauden aikaisen metformiini-altistuksen pitkäaikaiset vaikutukset lapseen Suomessa – CLUE-tutkimus | Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study. | Brand KM, Thoren R, Sõnajalg J, Boutmy E, Foch C, Schlachter J, et al. | BMJ Open Diabetes Research & Care, 10(6):e003056 | https://drc.bmj.com/content/10/6/e003056 |
| 2024 | Endometrial Cancer Real World Evidence Study in Finland: A Real-World study on patient characteristics, treatment patterns and outcomes of recurrent or advanced endometrial cancer patients in Finland | Healthcare resource utilisation (HCRU) and medical costs among patients with endometrial cancer in a real-world setting in Finland (the FIRE study). | Mascialino B, Aakko J, Kysenius K, Tuominen S, Idänpään-Heikkilä J, Käkelä S, Tikka S, Schneider D, Hietanen S, Lassus H, Auranen A | Poster, ISPOR Europe Meeting, Barcelona, Spain | |
| 2024 | TYÖOTE – HANKKEEN VAIKUTTAVUUSTUTKIMUS – Rekisteripohjainen arviointitutkimus vastuullisen asiakasohjausmallin etuisuusmaksu- ja tuottavuusvaikutuksista | Effectiveness of the Coordinated Return to Work model after orthopaedic surgery for lumbar discectomy and hip and knee arthroplasty: a register-based study. | Lavikainen P, Heiskanen J, Jalkanen K, Lehtimäki A-V, Vehkala S, Kangas P, Husman K, Vohlonen I, Martikainen J | Occupational and Environmental Medicine, 81:150–157 | https://doi.org/10.1136/oemed-2023-109276 |
| 2024 | Työkykyriskin ennustaminen ja korkeariskisten henkilöiden ryhmittely ennaltaehkäisevän työterveyshuollon tueksi | Associations of depressive symptoms and psychosocial working conditions with sickness absences in a Finnish cohort of 11,495 employees. | Anttila A, Nuutinen M, Van Gils M, Pekki A, Sauni R | Preventive Medicine Reports, 47 | https://authors.elsevier.com/sd/article/S2211-3355(24)00314-0 |
| 2024 | Kystisen fibroosin epidemiologia ja hoito Suomessa | Cystic fibrosis patient characteristics and healthcare resource utilisation in Finland using linked registries. | Malmivaara K, Pölkki M, Prami T, Raittinen P, Heikkilä E, Aalto A, Dunder T, Elenius V, Sandström K, McGarry LJ | Heliyon, 10:e33439 | https://www.cell.com/action/showPdf?pii=S2405-8440%2824%2909470-2 |
| 2024 | Ympäristö, geenit ja syöpäriski: seurantatutkimuksia Suomalaisessa kaksoskohortissa. | Novel epigenetic biomarkers for hematopoietic cancer found in twins. | Clemmensen SB, Frederiksen H, Mengel-From J, Heikkinen A, Kaprio J, Hjelmborg JV | Acta Oncologica, 63:710–717 | https://doi.org/10.2340/1651-226X.2024.40700 |
| 2024 | Finnish Diabetes Control study – FinDiCon | Increasing clinical inertia in basal insulin initiations in people living with type 2 diabetes in Finland | 23rd Nordic Congress of General Practice 2024; Turku, Finland; 11–14 June 2024 | ||
| 2024 | Finnish Diabetes Control study – FinDiCon | Trends in demographics and diabetes-related complications in people living with type 1 diabetes between 2014 and 2021 in Finland | 60th Annual Meeting European Association for the Study of Diabetes; Madrid, Spain; 10–13 September 2024 | ||
| 2024 | Sähköisten reseptien hyödyt ja kustannukset | Information Technology, Improved Access, and Use of Prescription Drugs | Böckerman P, Kortelainen M, Laine LT, Nurminen M, Saxell T | Journal of the European Economic Association 23(1):396–430 | https://doi.org/10.1093/jeea/jvae034 |
| 2024 | Sähköisten reseptien hyödyt ja kustannukset | Antidepressant Persistence Before and After the Introduction of Online Renewal | Kovalainen O-T | Master’s thesis, University of Helsinki | https://ethesis.helsinki.fi/repository/handle/123456789/2/browse?type=author&value=Kovalainen%2C+Olli-Tuomas |
| 2024 | lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimus | New reference limits for cardiac troponin T and N-terminal b-type natriuretic propeptide in elders | Heikkilä E, Katajamäki T, Salminen M, Irjala K, Viljanen A, Koivula M-K, Pulkki K, Isoaho R, Kivelä S-L, Viitanen M, Löppönen M, Vahlberg T, Viikari L | Clinica Chimica Acta 2024;556:117844 | https://doi.org/10.1016/j.cca.2024.117844 |
| 2024 | lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimus | Predicting successful ageing among older adults seems possible even as far as two decades ahead | Viljanen A, Salminen M, Irjala K et al. | BMC Geriatrics 2024;24:481 | https://doi.org/10.1186/s12877-024-02481-5 |
| 2024 | SOTE-PALVELUT LÄPINÄKYVIKSI: Palvelu- ja tietointegraatio yhtenäisen tietomallin ja yhdistetyn tietopohjan avulla | Societal costs of depression and outcomes of care in Finland | Näätänen P, Juntura J, Joffe G, Ekelund J, Nuutinen M, Leskelä R-L, Ito T, Rive B, Godinov Y, Eriksson I, Torkki P | ICHOM 2024 (Conference abstract) | |
| 2024 | Elämänkokemukset, ylisukupolviset prosessit ja perinataalivaiheen sosioekonomiset terveyserot (Life course experiences, intergenerational processes, and socioeconomic health inequalities in perinatal period) | Seasonality of Birth Weight in Singleton Full-term Births in Finland | Orderud H., Eskelinen N., Lindberg M. | Finnish Yearbook of Population Research, 57, 21–46 | https://doi.org/10.23979/fypr.136379 |
| 2024 | Elämänkokemukset, ylisukupolviset prosessit ja perinataalivaiheen sosioekonomiset terveyserot (Life course experiences, intergenerational processes, and socioeconomic health inequalities in perinatal period) | Low and very low birthweight disadvantage in compulsory education achievement and transition to upper secondary education | Lindberg M | . Child Care Health Dev, 50(2):e13243 | https://doi.org/10.1111/cch.13243 |
| 2024 | Kasvaingeenitutkimus | Cancer incidence following non-neoplastic medical conditions | Sipilä LJ, Tanskanen T, Heikkinen S, Seppä K, Aavikko M, Ravantti J, Aaltonen LA, Pitkäniemi J | Acta Oncologica, 63(1), 841–849 | https://doi.org/10.2340/1651-226X.2024.40757 |
| 2024 | Kasvaingeenitutkimus | Lynch syndrome-associated and sporadic microsatellite unstable colorectal cancers | Martin S, Katainen R, Taira A, Välimäki N, Ristimäki A, Seppälä T, Renkonen-Sinisalo L, Lepistö A, Tahkola K, Mattila A, Koskensalo S, Mecklin JP, Rajamäki K, Palin K, Aaltonen LA. | Human Molecular Genetics, 33(21):1858–1872 | https://doi.org/10.1093/hmg/ddae124 |
| 2024 | Kasvaingeenitutkimus | Non-stem cell lineages as an alternative origin of intestinal tumorigenesis | Verhagen MP., Joosten R., Schmitt M., Välimäki N., ym. | Nat Genet 56, 1456–1467 | https://doi.org/10.1038/s41588-024-01801-y |
| 2024 | Kasvaingeenitutkimus | Detection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohort | Sipilä LJ ym. | Familial Cancer 23, 647–652 | https://doi.org/10.1007/s10689-024-00400-4 |
| 2024 | Kasvaingeenitutkimus | Genome-wide somatic mutation analysis of sinonasal adenocarcinoma with and without wood dust exposure | Sipilä LJ ym. | Genes and Environ 46, 12 | https://doi.org/10.1186/s41021-024-00306-8 |
| 2024 | Trends in operative delivery rates in Estonia and Finland. | Caesarean section and operative vaginal delivery in Estonia and Finland from 1992 to 2016 | Sildver K., Veerus P., Gissler M., Lang K., Pisarev H. | European Journal of Public Health, 34(6):1205–1209 | https://doi.org/10.1093/eurpub/ckae162 |
| 2024 | Reseptien uudistaminen ja lääkehoidon seuranta – Rekisteritutkimus potilasta kohtaamatta uudistetuista lääkityksistä ja terveydenhuollon palvelujen käytöstä | Register-based study on prescription renewal without the prescriber meeting the patient | Rönngård-Jalkanen A., Aarnio E., Saastamoinen L., Timonen J. | Basic Clin Pharmacol Toxicol, 135(3): 321-333 | https://doi.org/10.1111/bcpt.14049 |
| 2024 | Työkyvyn tila Suomessa | Työkyky ja työhön osallistuminen – tuloksia työikäisen väestön ryhmittelystä | Turunen J, Siltala V, Henriksson M, Ahola E, Joensuu M | Työterveyslaitos, Työelämätieto-palvelu | https://www.tyoelamatieto.fi/fi/aineistot/tyokyky-ja-tyohon-osallistuminen-tuloksia-tyoikaisen-vaeston-ryhmittelysta |
| 2024 | Työkyvyn tila Suomessa | Työkyky ja työhön osallistuminen – vertailutuloksia työikäisen väestön ryhmittelystä | Turunen J, Siltala V, Henriksson M, Ahola E, Joensuu M | Työterveyslaitos, Työelämätieto-palvelu | https://www.tyoelamatieto.fi/fi/analyysit/tyokyky-ja-tyohon-osallistuminen-vertailutuloksia-tyoikaisen-vaeston-ryhmittelysta |
| 2024 | Työkyvyn tila Suomessa | Työikäiset ryhmiteltiin uudella tavalla – ryhmä- ja hyvinvointialuekohtaiset erot työhön osallistumisessa isoja | Työterveyslaitos | Työterveyslaitos | https://www.ttl.fi/ajankohtaista/tiedote/tyoikaiset-ryhmiteltiin-uudella-tavalla-ryhma-ja-hyvinvointialuekohtaiset-erot-tyohon |
| 2024 | Työkyvyn tila Suomessa | Työkyky ja työhön osallistuminen | Henriksson M | HVA työikäiset verkosto | |
| 2024 | Työkyvyn tila Suomessa | Työkyky ja työhön osallistuminen – vertailutuloksia työikäisen väestön ryhmittelystä | Turunen J | Kela seminaari | |
| 2024 | Työkyvyn tila Suomessa | Työkyky ja työhön osallistuminen | Henriksson M | Kela ja TTL verkkoseminaari | https://www.kela.fi/yhteistyokumppanit-koulutustallenteet#verkkoseminaari-1752024-kohti-yhteista-ymmarrysta-tyokyvysta-ja-sen-tukemisesta |
| 2024 | Työkyvyn tila Suomessa | Työkyky ja työhön osallistuminen | Henriksson M | THL seminaari | |
| 2024 | Työkyvyn tila Suomessa | Work Ability and Work Participation: Findings from a Register Study on Finland’s Working-Age Population | Turunen J, Siltala V, Henriksson M, Joensuu M, Ahola E | Nordic Working Life Conference, Roskilde, Denmark | |
| 2024 | Työkyvyn tila Suomessa | From Work Ability to Work Potential | Henriksson M, Joensuu M, Turunen J, Ahola E, Siltala V | 16th ESA Conference Porto, Portugal | |
| 2024 | Työkyvyn tila Suomessa | Mielenterveys sosiaali- ja terveysalalla sekä taide-, kulttuuri- ja tapahtuma-aloilla | Ahola E, Ropponen A | Työterveyslaitos, Työelämätieto-palvelu | https://www.tyoelamatieto.fi/fi/aineistot/mielenterveys-sosiaali-ja-terveysalalla-seka-taide-kulttuuri-ja-tapahtuma-aloilla |
| 2024 | Työkyvyn tila Suomessa | Sosiaali- ja terveysalalla sekä taide-, kulttuuri- ja tapahtuma-aloilla työskennelleiden mielenterveyden ja poissaolojen kehitys on vastaava kuin muilla aloilla | Ropponen A, Varje P | Työterveyslaitos, Työelämätieto-palvelu | https://www.tyoelamatieto.fi/fi/analyysit/sosiaali-ja-terveysalalla-seka-taide-kulttuuri-ja-tapahtuma-aloilla-tyoskennelleiden-mielenterveyden-ja-poissaolojen-kehitys-on-vastaava-kuin-muilla-aloilla |
| 2024 | Työkyvyn tila Suomessa | The role of mental health related healthcare use on work participation among unemployed | Salonen L, Solovieva S, Junna L, Pitkänen J, Kauhanen A, Leinonen T | 3rd International PEROSH Conference on Prolonging Working Life | |
| 2024 | Työkyvyn tila Suomessa | The role of mental health related healthcare use in employment and benefit use after unemployed | Salonen L, Solovieva S, Junna L, Pitkänen J, Kauhanen A, Leinonen T | European Journal of Public Health | https://doi.org/10.1093/eurpub/ckae144.726 |
| 2024 | Työkyvyn tila Suomessa | Hyvinvointialue työhön osallistumisen ekosysteemissä | Henriksson M, Joensuu M, Turunen J, Ahola E, Ervasti J, Siltala V | Työelämän tutkimuspäivät 2024 | |
| 2024 | Työkyvyn tila Suomessa | Työkyky ja työhön osallistuminen – vertailutuloksia työikäisen väestön ryhmittelystä | Turunen J, Siltala V, Ahola E, Henriksson M, Ahtinen S, Ervasti J, Joensuu M | Työelämän tutkimuspäivät 2024 | |
| 2024 | Työkyvyn tila Suomessa | The role of mental health related healthcare use in employment and benefit use after unemployed | Salonen L, Solovieva S, Junna L, Pitkänen J, Kauhanen A, Leinonen T | European Public Health Conference | |
| 2024 | Työkyvyn tila Suomessa | Työkyky ja työhön osallistuminen: Tuloksia ja havaintoja työkykyohjelman laajennoksen tutkimusosuudesta | Henriksson M, Joensuu M, Turunen J, Ahola E, Ervasti J, Siltala V | THL seminaari | https://innokyla.fi/sites/default/files/2024-11/Mikko%20Henriksson%20s%20pidennetty.pdf |
| 2024 | Työkyvyn tila Suomessa | Työikäisten työkyky ja työhön osallistuminen | Henriksson M, Siltala V | THL seminaari | https://innokyla.fi/sites/default/files/2024-12/TTL%20webinaari%203.12.2024.pdf |
| 2023 | FinMDS | Characteristics, treatment and outcomes of myelodysplastic syndrome in two Finnish hospital districts. | Tuominen S, Miettinen T, Dünweber C | medRxiv 2023.10.06.23296265 | https://doi.org/10.1101/2023.10.06.23296265 |
| 2023 | Ympäristö, geenit ja syöpäriski: seurantatutkimuksia Suomalaisessa kaksoskohortissa. | The association between night shift work and breast cancer risk in the Finnish twins cohort | Schernhammer E, Bogl L, Hublin C, Strohmaier S, Zebrowska M, Erber A, Haghayegh S, Papantoniou K, Ollikainen M, Kaprio J | Eur J Epidemiol. 38(5):533-543 | https://doi.org/10.1007/s10654-023-00983-9 |
| 2023 | Finnish Diabetes Control study – FinDiCon | Alle 60-vuotiaiden tyypin 2 diabeteksen hoitotasapaino on keskimääräistä huonompi | Vessari H, Luoto H, Aalto A, Peltonen E. J, Iso-Mustajärvi I, Raittinen P, Prami T, Saraheimo M, Valle T.T, Saukkonen T | Lääkärilehti 2023 | https://www.laakarilehti.fi/tieteessa/alkuperaistutkimukset/alle-60-vuotiaiden-tyypin-2-diabeteksen-hoitotasapaino-on-keskimaaraista-huonompi/ |
| 2023 | Valinnanvapaus ja kilpailu julkisessa erikoissairaanhoidossa | Improving Performance Through Allocation and Competition: Evidence from a Patient Choice Reform | Kortelainen M, Laine LT, Lavaste K, Saxell T, Siciliani L | VATT Working Papers 156 | https://vatt.fi/julkaisu?pubid=URN%3ANBN%3Afi-fe20231003138612 |
| 2023 | lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimus | A novel easy-to-use index to predict institutionalization and death in older population – a 10-year population-based follow-up study | Heikkilä E, Salminen M, Viljanen A, Katajamäki T, Koivula M-K, Pulkki K, Isoaho R, Kivelä S-L, Viitanen M, Löppönen M, Vahlberg T, Viikari L, Irjala K | BMC Geriatrics 2023;23:80 | https://doi.org/10.1186/s12877-023-03760-1 |
| 2023 | lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimus | Re-examination of successful agers with lower biological than chronological age still after a 20-year follow-up period | Viljanen A, Salminen M, Irjala K, Korhonen P, Vahlberg T, Viitanen M, Löppönen M, Viikari L. | BMC Geriatrics 2023;23:128 | https://doi.org/10.1186/s12877-023-03844-y |
| 2023 | Economic burden of medicines on households: De-commodification and re-commodification (DE-RE) | Austerity, economic hardship and access to medications: a repeated cross-sectional population survey study, 2013–2020 | Aaltonen K | J Epidemiol Community Health 2023;77:160-167 | https://doi.org/10.1136/jech-2022-219706 |
| 2023 | Economic burden of medicines on households: De-commodification and re-commodification (DE-RE) | Lääkkeistä tinkiminen yleistyi hallituksen kovien säästötoimien aikaan | Aaltonen K | INVEST Blog | https://blogit.utu.fi/invest/2023/01/31/laakkeista-tinkiminen-yleistyi-hallituksen-kovien-saastotoimien-aikaan/ |
| 2023 | Elämänkokemukset, ylisukupolviset prosessit ja perinataalivaiheen sosioekonomiset terveyserot (Life course experiences, intergenerational processes, and socioeconomic health inequalities in perinatal period) | Birth Weight, Maternal Education, and NEET Status in Young Adulthood: Evidence Using Sibling Fixed-effects | Eskelinen N., Salonen L., Kotimäki S., Lindberg M., Härkönen J. | INVEST Working Paper 79, SocArXiv | https://doi.org/10.31235/osf.io/epfbz |
| 2023 | Elämänkokemukset, ylisukupolviset prosessit ja perinataalivaiheen sosioekonomiset terveyserot (Life course experiences, intergenerational processes, and socioeconomic health inequalities in perinatal period) | Low and Very Low Birthweight Disadvantage in Compulsory Education Achievement… | Lindberg M | INVEST Working Paper 76, SocArXiv | https://doi.org/10.31235/osf.io/dk369 |
| 2023 | Trends in operative delivery rates in Estonia and Finland. | Cesarean section trends from 1992 to 2016 in Estonia and Finland | Sildver K., Veerus P., Lang K., Pisarev H., Gissler M. | Acta Obstet Gynecol Scand. 2023; 102: 1007-1013 | https://doi.org/10.1111/aogs.14609 |
| 2023 | Entisten huippu-urheilijoiden sairastuvuus- ja kuolleisuustutkimus; fyysisesti aktiivisen elämäntavan pitkäaikaisvaikutukset terveyteen, toimintakykyyn ja kansansairauksien riskitekijöihin. | Dementia in former amateur and professional contact sports participants: population-based cohort study, systematic review, and meta-analysis | Batty GD, Frank P, Kujala UM, Sarna SJ, Valencia-Hernández CA, Kaprio J | eClinicalMedicine, Volume 61, 102056 | https://doi.org/10.1016/j.eclinm.2023.102056 |
| 2023 | Entisten huippu-urheilijoiden sairastuvuus- ja kuolleisuustutkimus; fyysisesti aktiivisen elämäntavan pitkäaikaisvaikutukset terveyteen, toimintakykyyn ja kansansairauksien riskitekijöihin. | Suicide and depression in former contact sports participants: population-based cohort study, systematic review, and meta-analysis | Batty GD, Frank P, Kujala UM, Sarna SJ, Kaprio J | EClinicalMedicine, Volume 60, 102026 | https://doi.org/10.1016/j.eclinm.2023.102026 |
| 2022 | Ympäristö, geenit ja syöpäriski: seurantatutkimuksia Suomalaisessa kaksoskohortissa. | Differences in DNA Methylation-Based Age Prediction Within Twin Pairs Discordant for Cancer | Bode HF, Heikkinen A, Lundgren S, Kaprio J, Ollikainen M | Twin Res Hum Genet. 25(4-5):171-179 | https://doi.org/10.1017/thg.2022.32 |
| 2022 | Sähköisten reseptien hyödyt ja kustannukset | Information Integration, Coordination Failures, and Quality of Prescribing | Böckerman P, Laine LT, Nurminen M, Saxell T | The Journal of Human Resources (published ahead of print December 7, 2022) | https://jhr.uwpress.org/content/early/2022/12/01/jhr.0921-11910R2 |
| 2022 | lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimus | Ceramides and phosphatidylcholines associate with cardiovascular diseases in the elderly | Katajamäki T, Koivula M-K, Hilvo M, Lääperi M, Salminen M, Viljanen A, Heikkilä E, Löppönen M, Iso-aho R, Kivelä S-L, Jylhä A, Viikari L, Irjala K, Pulkki K, Laaksonen R | Clin Chem 2022. | https://doi.org/10.1093/clinchem/hvac158 |
| 2022 | Kehitysvammaisten lääkehoito ja asumispalvelut Suomessa. | Medicine use in people with intellectual disabilities: a Finnish nationwide register study | Nurminen F, Rättö H, Arvio M, Teittinen A, Vesala H. T., Saastamoinen L. | Journal of Intellectual Disability Research, 67: 1291–1305 | https://doi.org/10.1111/jir.12988 |
| 2022 | Uudenlaisen, systeemisen lääkehoidon persistenssi ja adherenssi keskivaikean tai vaikean läiskä- tai nivelpsoriaasin hoidossa – Rekisteripohjainen kohorttitutkimus Suomessa ja Ruotsissa | Persistence of advanced systemic pharmacological treatment of moderate-to-severe psoriasis among bio-naïve patients | G. Tskhvarashvili, K. Aher, I. Sveide, U. Katus, A. Westerlund, F. Hoti, C. Wennerström, F. Hassan, J. Lee, C. Hermanrud, I. Johnsson, A. Passey, R. Nissinen, S. Polesie, T. Mälkönen, L. Saarelainen | J Eur Acad Dermatol Venereol. 2025; 39(Suppl. 1): 50–64 | https://onlinelibrary.wiley.com/doi/10.1111/jdv.20198 |
| 2022 | Long Acting Injectable Buprenorphine Use in Finland | Early experience of buprenorphine long-acting injection in Finland: a retrospective cohort study | 15th European Congress on Heroin Addiction, Pisa | ||
| 2022 | Entisten huippu-urheilijoiden sairastuvuus- ja kuolleisuustutkimus; fyysisesti aktiivisen elämäntavan pitkäaikaisvaikutukset terveyteen, toimintakykyyn ja kansansairauksien riskitekijöihin. | Longitudinal Associations of High-Volume and Vigorous-Intensity Exercise With Hip Fracture Risk in Men | Korhonen MT, Kujala UM, Kettunen J, Korhonen OV, Kaprio J, Sarna S, Törmäkangas T | J Bone Miner Res, (8):1562-1570 | https://doi.org/10.1002/jbmr.4624 |
| 2021 | lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimus | A practical laboratory index to predict institutionalization and mortality – an 18-year population-based follow-up study | Heikkilä E, Salminen M, Viljanen A, Katajamäki T, Koivula M-K, Pulkki K, Isoaho R, Kivelä S-L, Viitanen M, Löppönen M, Vahlberg T, Viikari L, Irjala K | BMC Geriatrics, 21, 139 (2021) | https://doi.org/10.1186/s12877-021-02077-1 |
| 2021 | lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimus | Subjective and objective health predicting mortality and institutionalization: an 18-year population-based follow-up study | Viljanen A, Salminen M, Irjala K, Heikkilä E, Isoaho R, Kivelä S-L, Korhonen P, Vahlberg T, Viitanen M, Wuorela M, Löppönen M, Viikari L. | BMC Geriatrics 2021;21:358 | https://doi.org/10.1186/s12877-021-02311-w |
| 2021 | lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimus | Chronic conditions and multimorbidity associated with institutionalization among Finnish community-dwelling older people | Viljanen A, Salminen M, Irjala K, Heikkilä E, Isoaho R, Kivelä S-L, Korhonen P, Vahlberg T, Viitanen M, Wuorela M, Löppönen M, Viikari L | Eur Geriatr Med 2021. | https://doi.org/10.1007/s41999-021-00535-y |
| 2021 | Älykäs luu – Koneoppimiseen perustuva DXA-kuvien analyysi potilaiden diagnostiikassa. | Detecting pathological features and predicting fracture risk from dual-energy X-ray absorptiometry images using deep learning | Nissinen T, Suoranta S, Saavalainen T, Sund R, Hurskainen O, Rikkonen T, Kröger H, Lähivaara T, Väänänen SP | Bone reports 2021 101070 | https://doi.org/10.1016/j.bonr.2021.101070 |
| 2020 | Valinnanvapaus ja kilpailu julkisessa erikoissairaanhoidossa | Effects of Maternity Ward Closures on Maternal Health in Finland | Hägg M | University of Eastern Finland, Master’s thesis | https://erepo.uef.fi/bitstream/handle/123456789/23053/urn_nbn_fi_uef-20200932.pdf |
| 2020 | Sähköisten reseptien hyödyt ja kustannukset | Information Integration, Coordination Failures, and Quality of Prescribing | Böckerman P, Laine LT, Nurminen M, Saxell T | VATT Working Papers 135 | https://vatt.fi/julkaisu?pubid=URN%3AISBN%3A978-952-274-260-5 |
| 2020 | lkääntyneiden sydän- ja verisuonisairastuvuus ja kuolleisuus – seurantatutkimus | Frailty, walking ability and self-rated health predicting institutionalization; an 18-year follow-up among Finnish community-dwelling older people | Viljanen A, Salminen M, Korhonen P, Irjala K, Wuorela M, Isoaho R, Kivelä S-L, Viitanen M, Löppönen M, Viikari L | Aging Clin Exp Res 2020 | https://doi.org/10.1007/s40520-020-01551-x |
| 2020 | Työkyvyn tila Suomessa | Labor Market Participation Before and After Long-Term Part-Time Sickness Absence in Finland: A Population-Based Cohort Study | Ervasti J, Kausto J, Koskinen A, Pentti J, Vahtera J, Joensuu M, Turunen J, Oksanen T, Kivimäki M | Journal of Occupational and Environmental Medicine | https://journals.lww.com/joem/fulltext/2020/04000/labor_market_participation_before_and_after.11.aspx |
Frequently asked questions
How does Findata process applications?
- Contact data controllers directly for additional information on data or variables.
- Data controllers provide additional information about their own datasets.
- You may also request a cost estimate and an assessment of the feasibility of the data extraction.
- Use the extraction description form to define your data extractions.
- Use tabulation plan to describe the statistics generation if you are applying for a statistical data.
- If you agree on any special arrangements with the data controller, please mention these in the Additional information section of your application.
- Submit your application via Findata’s e-service
- Log in to the e-service: asiointi.findata.fi
- Findata reviews the application and invites you to an online meeting
- We review applications within approximately one week of submission.
- We invite the applicant to a Teams meeting to go through the application and ask clarifying questions if needed.
- We may ask you to supplement the application.
- Findata requests cost estimates and additional information from data controllers
- Once the extraction descriptions are complete, we will send requests for additional information and cost estimates to the relevant data controllers.
- Data controllers have 15 working days to respond.
- If further clarification is needed, data controllers may send questions via Findata to the applicant.
- Findata compiles the cost estimates from data controllers and Findata’s own data processing costs and sends them to the applicant.
- After receiving the cost estimates from data controllers, we assess the working time and costs required for data processing.
- We then deliver the final extraction description and cost estimate to the applicant.
- The extraction description must be approved before a permit can be granted.
- Extraction terms cannot be changed after approval. Any later changes to the extracted data require a separate application.
- Findata issues a decision
- Data permits are for a fixed period.
- If data needs to be retained, for example for research verification purposes, or if permit renewal or regular updates of data extractions are expected, please indicate this in the application.
How does Findata compile datasets?
- Findata sends data extraction requests to controllers who extract the data
- Each controller has 30 working days to submit the requested data to Findata.
- The extraction may involve multiple steps, such as:
- Extraction of the target group
- Extraction of controls
- Extraction of additional data
- Each step can take up to 30 working days, potentially totaling up to 90 working days.
- Findata pre-processes the extracted data
- We will review, combine, and pseudonymise the data or generate statistics according to the data request.
- Findata delivers the data to the permit holder
- The processed data will be provided to a secure processing environment (SPE), typically in CSV format.
- Data may be disclosed to any SPE compliant with the Act on Secondary Use.
- The target time for delivering the data is 60 working days.
- This timeframe may be extended if the target group is not provided immediately, if extraction is conducted in multiple stages, if there are delays from controllers, or if the data is particularly complex.
- Permit holder reviews the data
- You have three months to review the data and notify Findata of any discrepancies or comments.
- Thoroughly check the data, as errors can lead to additional work.
- For example, errors that occur during extraction can accumulate, such as if the target group is formed incorrectly, requiring additional extractions from other controllers.
- If you find omissions or errors, email Findata at data@findata.fi with detailed descriptions of how your data differs from the extraction description.
- Findata deletes the data from its own processing systems once the retention period has expired.
- We remove the datasets from our systems four months after delivery.
- We retain the code keys for pseudonymised data to allow reproduction if needed.
- Data permits are for a fixed period.
- If you need to save data for purposes like research verification, plan to renew the permit, or require regular updates, include these needs in your application.
When do I submit an application to Findata?
Submit your data permit, data request or amendment permit application to Findata if you want to apply for:
- Data from several public social and health sector controllers covered by the Secondary Use Act.
- Data from a single public controller that has transferred the right to issue permits to Findata (see list of these)
- Data from one or more private social welfare and health care service organisers.
- Customer data saved in the Kanta Services.
- Findata’s ready-made dataset.
You can check authority with Application Assistant.
What is a data controller?
A data controller is a person or organisation that decides on the processing of personal data. They are responsible for ensuring that data processing is carried out securely and appropriately, and that the data is either destroyed or archived properly once the research is completed.
If the researcher is employed by the organisation conducting the research, that organisation acts as the data controller. However, an independent researcher or research group can act as the data controller themselves.
If multiple organisations jointly decide on the processing of personal data, they act as joint data controllers. In such cases, it is important to clearly agree on the responsibilities of each party.
Can data obtained from Findata be processed alongside other data?
Data authorised by Findata can be processed in the same processing environment as other data, such as data collected by the applicant themselves or data obtained under a separate permit. At Findata, this is referred to as combining data.
Combining data is possible in:
- the centralised permit model (Findata as the sole permit authority), and
- the distributed permit model (multiple organisations granting permits, one of which is Findata)
As a rule, combining data is the responsibility of Findata or Statistics Finland.
Read more: Combining datasets authorised by Findata with other data sources
How do data controllers deliver extracted datasets to Findata?
Data controllers deliver the extracted datasets to Findata via secure Tunnel and Supertunnel transfer services.
Instructions for data controllers on delivering extracted datasets: Data transfers
Can I apply for data from Findata for my thesis?
You can apply for data from Findata for your thesis if you are working on a thesis for at least a higher university degree. In your application, please specify your educational institution, the degree being pursued, the thesis author, and the thesis supervisor.
The licence fees for theses are reduced. The reduced thesis licence fee applies when producing a single thesis. If the project produces multiple theses or other outputs unrelated to the thesis, the normal or extended licence fee will apply.
Tips for defining the extraction of textual data
- Consider necessity: Determine if textual data is essential for conducting your research.
- The need for unstructured data must always be justified. Often, similar information can be extracted in a structured format.
- We mask direct identifiers in textual data, which affects the usability of the data.
- Processing textual data takes time and significantly increases costs.
- Request insights from the data controller on appropriate keywords.
- The data controller is best positioned to assess which keywords will yield the most comprehensive results without extraneous information.
- For example, the keyword pressure will produce all records related to pressure, such as blood pressure, eye pressure, etc. If the research focus is on blood pressure, the extracted textual data will contain a substantial amount of unnecessary information.
- Specify the length of the text snippet to be extracted on a variable-by-variable basis.
- The text snippet should be as short as possible.
- Request the data controller’s view on the length of the text to be extracted.
- For instance, keyword +/- 50 characters.
- Ensure the extraction is scoped appropriately.
- If the extraction can be limited to the information from a specific department or field of treatment instead of the entire healthcare district’s database, the amount of text to be extracted and the processing costs will be significantly lower.
How can I ensure that the contents of my application remain confidential?
Applications received by Findata are confidential, while Findata’s decisions are public. If a data controller has a statutory right to access information about the application’s contents, Findata may, on a case-by-case basis, provide the data controller with information about the data to be extracted and the formation of the target group.
What is a data utilisation or research plan?
A data utilisation plan refers to a research plan, project plan, or a similar plan.
The plan must specify:
- the purpose of using the data as stated in the permit application,
- the data controller and processors,
- the legal basis for processing, and
- essential aspects related to data protection and information security covering the entire data lifecycle (storage, disposal, or archiving of data).
The essential elements of the data utilisation plan are addressed in Findata’s application forms.
Common criteria for scientific research include, for example:
- the research is based on an appropriate research plan,
- the research has a responsible person or a responsible group,
- the research participates in scientific discourse, meaning the results are intended to be published according to scientific principles, for example in scientific journals or as a thesis,
- the research produces new knowledge or promotes public health or wellbeing,
- the research has a research permit granted by the relevant organisation, if such a permit is required,
- medical research has a favourable statement from an ethics committee.
An appropriate scientific research plan typically includes, for example:
- background information,
- definition of the information needs the research aims to address,
- setting goals and research questions,
- description of the required data and methods, and
- consideration of ethical perspectives.
How to speed up the processing of your amendment application
Processing time for your application depends on several factors, including the clarity of your application, our current processing load, and response times from data controllers. To expedite the process:
- Complete the application carefully ensuring all sections are filled out thoroughly and accurately.
- Attach all previous permit decisions to your application.
- Attach to your application all previous non-disclosure agreements (NDA). Each person handling the material to be added must have their own NDA.
- Use Findata’s advisory service for additional support and clarification.
For more information, visit the Data page or check the Data Resources Catalogue (aineistokatalogi.fi).
What is the EHDS?
The European Health Data Space (EHDS) is a regulation of the European Union that establishes a common framework for the use and exchange of health data in EU countries. The aim of the regulation is to strengthen citizens’ rights to their own electronic health data and to enable the secure cross-border secondary use of health data.
The EHDS regulation is similar to the current Finnish Secondary Use Act, but it also introduces changes. The regulation includes partly different purposes of use, some of which are reserved only for public or EU entities. In addition, new operating models will be introduced for processing data requests and permit applications.
The regulation entered into force in March 2025 and will be implemented gradually over the coming years. The parts concerning secondary use will begin to apply in March 2029.
What are personal data?
Personal data are pieces of information that can be used to identify an individual either directly or indirectly.
Examples of personal data that allow direct identification include:
- name,
- personal identity code,
- email address based on the person’s name, and
- biometric identifiers such as fingerprints, facial images, voice, and iris patterns.
Examples of personal data that allow indirect or partial identification include:
- gender,
- age,
- education, and
- nationality.
Indirect or partial identifiers can also be combined to identify a person. Therefore, removing or replacing direct personal identifiers does not necessarily mean that the data no longer contains personal data.
Special categories (or sensitive) personal data include, for example:
- ethnic origin,
- sexual orientation or behaviour,
- health data,
- biometric data, and
- genetic data.
Highly protected personal data include, for example:
- psychiatric data,
- social welfare data, and
- data related to sexually transmitted diseases and medical genetics.
How does the data controller provide the extracted data to Findata?
For instructions on how data controllers can submit extracted data, see the Data transfers to Findata -page.
What is anonymisation and pseudonymisation?
Anonymisation means the transformation of personal data into a form that irreversibly prevents the identification of an individual person. This may mean, for example, removing direct identifiers and simplifying the data to a general level so that personal data cannot be reconstituted in any way.
Pseudonymisation refers to the transformation of personal data, for example into a coded form. In this case, names and personal identifiers can be removed and replaced by another unique identifier, i.e. a code. Often a code key is kept to restore direct personal data to the data. Pseudonymised data are still personal data.
Can I collect the data myself from my own hospital and thus avoid the data controller’s collection fee?
Yes, you can, if this is okay with the controller. The controller has the right to determine independently the manner in which it carries out the extraction, and it has the right to use an external processor to carry out the data extraction.
If such processors are used, the EU General Data Protection Regulation (GDPR) requires that a data protection agreement (DPA) covering the processing of personal data is signed with them. The controller is ultimately responsible for ensuring that the personal data is processed in a legal manner. The processor, meanwhile, is responsible for ensuring that it complies with the terms of the DPA and the instructions of the controller.
The collected data must be delivered to Findata securely via the transfer service Tunneli, after which we combine and pre-process them.
How can I modify an application I have sent?
Unfortunately, you cannot yourself modify an application after it has sent.
If you want to supplement an application that has already been sent, send us an email to info@findata.fi and tell us your application’s ID (e.g. 2022/53). We will return the application so you can supplement it.
How to speed up the processing of your application
- Check whether Findata is the competent authority to issue a permit for the data you need.
- Use Application assistant
- If you are unsure where your application should be submitted, please contact our advisory service before submitting your application: info@findata.fi.
- If you need more information about the data or variables, contact the relevant data controllers directly.
- Data controllers provide advisory services for their data and can guide you on data extraction methods.
- You may also agree on the details of data extraction directly with the data controller. If you do so, please include the name of the person you have agreed this with in your application.
- Read more: Links to data controllers’ websites and data descriptions
- Specify your data needs and dataset extraction requirements as precisely as possible for each data controller.
- Use the extraction description form to define your data extractions: Extraction description form (Word file, 51.2 kb)
- Use tabulation plan form to describe the statistics generation if you are applying for a statistical: Tabulation plan (Excel file, 19,2 kB)
- Use the Data Resources Catalogue (aineistokatalogi.fi)
- Ensure appropriate scope of data extraction
- The disclosure of personal data is governed by the GDPR principle of data minimisation. This means that only the data that is strictly necessary may be disclosed.
- Data extraction may still be broad, as long as the need for the data is justified.
- Complete your application carefully
- Pay particular attention to basic information such as the applicant, the data controller of the dataset to be disclosed, billing details, and any other datasets to be linked.